Volume 15 - Issue 12 - December 2002
News and Trends »
In the wake of increasing threats of resistant bacteria strains such as MRSA, new data presented at the 40th Annual Meeting of the Infectious Diseases Society of America provides some hope. Researchers revealed that linezolid may have promise in treating diabetic foot infections caused by bacteria such as Staphylococcus aureus.
According to the results of the study, which involved over 350 patients at U.S. and European sites, 81.3 percent of the linezolid patients were “clinically cured,” compared to 71.3 percent of patients who received a standard aminopenicillin combination.
Sports Medicine »
Chronic overuse problems that persist despite appropriate care are the hallmarks of a leg length discrepancy (LLD) in an athlete. While the symptoms associated with LLDs are diverse and, at times, vague and confusing, you should suspect limb length asymmetry when athletes have back or lower extremity complaints. Leg length asymmetries appear to be the third most common cause of running injuries and occur in 60 to 90 percent of the population.
In regard to classifying LLD, the two major categories are structural and functional. The one minor category is environmental.
Technology In Practice »
Podiatrists are adding the OsteoSet Resorbable Mini-Bead Kit to their arsenal of treatments for osteomyelitis and diabetic foot infections. One prospective study reports that bone repair with the OsteoSet yielded a 98 percent success at 12 months for contained defects, according to the product’s manufacturer Wright Medical.1 For defects specifically caused by osteomyelitis, a different retrospective study reports a 64 percent healing rate.2
Those who have used the product in their practice have also seen favorable results. In the past year, Ritchard Rosen, DPM, says he
Managed Care Insider »
Upgrading your office technology can give you a host of ailments, both real and imagined. First, there’s the headache associated with researching and selecting a system that’s right for your practice. Then there’s the whiplash that occurs at the thought of keeping up with the daunting pace of that technology—its configuration and interminable upgrades. Lastly, there’s the churning of the stomach that happens once everything is in place, as you mull over whether you made the right decision.
Of course, the decision to embrace practice management technology is one that you must make at
Diabetes Watch »
When it comes to peripheral vascular disease, you can use many modalities to detect and evaluate this disease. Arteriography is the gold standard and provides excellent anatomic detail, but it is invasive and requires ionizing radiation and administration of contrast. It also provides very limited physiologic or functional information.
Indeed, it’s important to be aware of the role of noninvasive testing measures (see “When NIV Studies Are Warranted”). After all, Pellerito, et. al., pointed out it’s advantageous to use noninvasive vascular (NIV) evaluation prior to angiography in ord
Orthotics Q&A »
As December arrives, patients who enjoy winter sports begin to think about skiing. Ski boot technology has come a long way in recent years, with many comfort features added to complement the performance the boots are designed to provide. Patients will often ask your opinion as to what they need and how they can enhance their skiing. With this in mind, our expert panelists offer their opinions.
Q: What are the most interesting advances now available in ski boots for the upcoming season?
A: In the past five years, ski boots have moved in a few directions, according to Ben Wax, CPe
- « Previous
- | Page 1 of 2 |
- Next »